Teva Pharmaceuticals Europe BV

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 28 Apr 2015
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 768132910081-67

Overview

Lobbying Costs

550,000€

Financial year: Jan 2014 - Dec 2014

Lobbyists (Full time equivalent)

2.75 Fte (5)

Lobbyists with EP accreditation

2

High-level Commission meetings

3

Lobbying Costs over the years

  • Info

    Teva Pharmaceuticals Europe BV   (Teva)

    EU Transparency Register

    27116427434-57 First registered on 14 Dec 2011

    Goals / Remit

    Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 10 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide, of which more than 54,000 in the European Union.

    Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).

    Main EU files targeted

    Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical legislation, European external trade agenda, European semester, global health.

    Address

    Head Office
    PIET HEINKADE, 107
    Amsterdam 1019
    NETHERLANDS
    EU Office
    20 Square Vergote
    Brussels 1030
    BELGIUM
  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    75%2
    50%2
    25%1

    Lobbyists (Full time equivalent)

    2.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 28 Apr 2015

    Name Start date End Date
    Josef KUNRT 05 Mar 2024 04 Mar 2025
    Veronica ZILLI 05 Mar 2024 04 Mar 2025
    Erick TYSSIER 05 Mar 2024 04 Mar 2025
    Mr Josef KUNRT 05 Mar 2024 15 Apr 2024
    Ms Veronica Zilli 05 Mar 2024 15 Apr 2024
    Mr Erick Tyssier 05 Mar 2024 15 Apr 2024
    Mr Erick Tyssier 18 Mar 2023 11 Mar 2024
    Mr Josef KUNRT 04 Mar 2023 11 Mar 2024
    Ms Veronica Zilli 04 Mar 2023 11 Mar 2024
    Mr Erick Tyssier 06 Oct 2021 06 Oct 2022
    Mr Andrea Zanaglio 06 Oct 2021 06 Oct 2022
    Mr Andrea Zanaglio 17 Dec 2019 17 Dec 2020
    Mr Erick Tyssier 17 Dec 2019 17 Dec 2020
    Mr Goncalo PINTO MENDES 17 Dec 2019 17 Dec 2020
    Mr Andrea Zanaglio 29 Nov 2018 01 Dec 2019
    Mr Erick Tyssier 29 Nov 2018 01 Dec 2019
    Mr Andrea Zanaglio 09 Dec 2017 29 Nov 2018
    Mr Erick Tyssier 09 Dec 2017 29 Nov 2018
    Mr Alberto Giummarra 09 Dec 2017 02 May 2018
    Mr Andrea Zanaglio 08 Dec 2016 07 Dec 2017
    Ms Isabel Klinnert Vlachopoulou 08 Dec 2016 07 Dec 2017
    Mr Erick Tyssier 08 Dec 2016 07 Dec 2017
    Mr Andrea Zanaglio 15 Dec 2015 08 Dec 2016
    Ms Isabel Klinnert Vlachopoulou 15 Dec 2015 08 Dec 2016
    Mr Erick Tyssier 15 Dec 2015 08 Dec 2016
    Ms Isabel Klinnert Vlachopoulou 13 Dec 2014 11 Dec 2015
    Mr Andrea Zanaglio 13 Dec 2014 11 Dec 2015
    Mrs Isabel Klinnert Vlachopoulou 13 Dec 2014 27 Jan 2015
    Mr Erick Tyssier 17 Apr 2014 16 Apr 2015
    Mr Marcel Daniels 12 Nov 2013 17 Apr 2014
    Mr Marcel DANIËLS 28 Nov 2012 20 Nov 2013
    Mr Marcel DANIËLS 17 Jan 2012 28 Nov 2012

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Tyssier Erick (Head of Government Affairs Europe)

    Person with legal responsibility

    Mr Bhattacharjee Dipankar (President and CEO, Teva Pharmaceuticals Europe BV)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    European Generic Medicines Association (EGA)
    Friends of Europe
    AECA
    EPF

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2014 - Dec 2014

    Lobbying costs for closed financial year

    550,000€

    Other financial info

    Brussels office is composed of 3 people. 2 spending 75% (one arrived in August, the other one in November 2014) of their time on policy and advocacy activities and 1 additional personal spending 50% of his time. Financial information includes project costs, trade organisation fees together with our office facilities and travel related costs.

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    - stainability, Quality and Access to thcare systems
    - ealth / mHealth
    - industrial policy Initiatives
    - corporate social responsibility

    Other activities

    None declared

  • Meetings

    Meetings

    3 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard